Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 55
Filter
1.
Health Phys ; 87(6): 625-41, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15545769

ABSTRACT

Luminescence retrospective dosimetry techniques have been applied with ceramic bricks to determine the cumulative external gamma dose due to fallout, primarily from the 1949 test, in populated regions lying NE of the Semipalatinsk Nuclear Test Site in Altai, Russia, and the Semipalatinsk region, Kazakhstan. As part of a pilot study, nine settlements were examined, three within the regions of highest predicted dose (Dolon in Kazakshstan; Laptev Log and Leshoz Topolinskiy in Russia) and the remainder of lower predicted dose (Akkol, Bolshaya Vladimrovka, Kanonerka, and Izvestka in Kazakshstan; Rubtsovsk and Kuria in Russia) within the lateral regions of the fallout trace due to the 1949 test. The settlement of Kainar, mainly affected by the 24 September 1951 nuclear test, was also examined. The bricks from this region were found to be generally suitable for use with the luminescence method. Estimates of cumulative absorbed dose in air due to fallout for Dolon and Kanonerka in Kazakshstan and Leshoz Topolinskiy were 475 +/- 110 mGy, 240 +/- 60 mGy, and 230 +/- 70 mGy, respectively. The result obtained in Dolon village is in agreement with published calculated estimates of dose normalized to Cs concentration in soil. At all the other locations (except Kainar) the experimental values of cumulative absorbed dose obtained indicated no significant dose due to fallout that could be detected within a margin of about 25 mGy. The results demonstrate the potential suitability of the luminescence method to map variations in cumulative dose within the relatively narrow corridor of fallout distribution from the 1949 test. Such work is needed to provide the basis for accurate dose reconstruction in settlements since the predominance of short-lived radionuclides in the fallout and a high degree of heterogeneity in the distribution of fallout are problematic for the application of conventional dosimetry techniques.


Subject(s)
Luminescent Measurements , Radioactive Fallout , Radiometry
3.
Med Radiol (Mosk) ; 34(10): 44-8, 1989 Oct.
Article in Russian | MEDLINE | ID: mdl-2811628

ABSTRACT

A comparative study of the effect of rectal administration of metronidazole on radiosensitivity of cervical cancer with relation to tumor sizes and a Hb level was conducted. The effect of a direct tumor reaction on survival was investigated. Rectal administration of metronidazole proved to be effective in large tumor sizes and a low Hb level. The use of metronidazole resulted in an increase in the number of patients with complete tumor regression and an increase in their survival. A low Hb level is an independent prognostic factor in radiation therapy of cervical cancer leading to an increase in tumor radiosensitivity.


Subject(s)
Metronidazole/therapeutic use , Radiation-Sensitizing Agents/therapeutic use , Uterine Cervical Neoplasms/radiotherapy , Administration, Rectal , Combined Modality Therapy , Female , Hemoglobins/analysis , Hemoglobins/physiology , Humans , Metronidazole/administration & dosage , Radiation-Sensitizing Agents/administration & dosage , Uterine Cervical Neoplasms/blood , Uterine Cervical Neoplasms/drug therapy
4.
Med Radiol (Mosk) ; 34(4): 26-30, 1989 Apr.
Article in Russian | MEDLINE | ID: mdl-2709959

ABSTRACT

The paper is concerned with analysis of the results of radiation therapy of cervical cancer and intratumoral administration of metronidazole (124 patients with tumors, Stage IIB and III). At the end of the treatment, complete tumor regression in the intervention group (with metronidazole) was noted in 91% (irrespective of a stage of disease), in the control group (without metronidazole)--in 51% of the patients.


Subject(s)
Metronidazole/administration & dosage , Uterine Cervical Neoplasms/radiotherapy , Adult , Aged , Combined Modality Therapy , Female , Humans , Metronidazole/therapeutic use , Middle Aged , Uterine Cervical Neoplasms/drug therapy
5.
Int J Radiat Oncol Biol Phys ; 16(4): 1061-3, 1989 Apr.
Article in English | MEDLINE | ID: mdl-2649461

ABSTRACT

In a recently started clinical trial, the short-term effects of radiotherapy of cervix cancer Stage IIb and III in combination with topical infusion of metronidazole solution were evaluated by determining the local clearance rate and cytologic damage in randomized and non-randomized cases. In regard to the short term effects the combined treatment was found to be superior to treatment without metronidazole.


Subject(s)
Metronidazole/therapeutic use , Uterine Cervical Neoplasms/radiotherapy , Clinical Trials as Topic , Combined Modality Therapy , Female , Humans , Metronidazole/administration & dosage , Random Allocation
6.
Vopr Onkol ; 35(11): 1319-22, 1989.
Article in Russian | MEDLINE | ID: mdl-2609521

ABSTRACT

Thirty-four breast carcinomas revealed unequal growth rates their doubling time ranging 12-150 days. Steroid hormone levels and immunologic vigor were found to significantly differ in patients with different growth rates. Higher rates were associated with more pronounced systemic disorders.


Subject(s)
Breast Neoplasms/blood , Estradiol/blood , Hydrocortisone/blood , Testosterone/blood , Adult , B-Lymphocytes/immunology , Breast Neoplasms/immunology , Breast Neoplasms/pathology , Female , Humans , Middle Aged , Neoplasm Staging , Radioimmunoassay , Rosette Formation , T-Lymphocytes/immunology , Time Factors
7.
Med Radiol (Mosk) ; 33(5): 9-13, 1988 May.
Article in Russian | MEDLINE | ID: mdl-3374309

ABSTRACT

The authors made a retrospective comparative analysis of the results of treatment of 336 lung cancer patients using surgical, radiation and drug techniques taking into account the rate of tumor growth. Differences were observed both in the frequency and terms of survival rates in surgical treatment and markedness of regressive changes in conservative methods of treatment.


Subject(s)
Lung Neoplasms/therapy , Aged , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Cyclophosphamide/administration & dosage , Doxorubicin/administration & dosage , Female , Humans , Lung Neoplasms/pathology , Male , Middle Aged , Pneumonectomy , Prospidium/administration & dosage , Radioisotope Teletherapy , Retrospective Studies , Thoracotomy
8.
Med Radiol (Mosk) ; 33(1): 36-40, 1988 Jan.
Article in Russian | MEDLINE | ID: mdl-3339976

ABSTRACT

The paper is concerned with the results of combined radiotherapy of 60 esophageal cancer patients. Indications for combined radiotherapy were the minimum lumen of the esophagus (8-10 mm), limited local spreading of a tumor, and the absence of distant metastases. Among the patients there were 46 men, 14 women, their mean age was 56-8.3 yrs. The mean duration of life of the dead patients was 16.2-7.2 months. No cardiac or pulmonary complications were observed. The 3-year survival rate was 26.4-6.9% and the 5-year survival rate was 17.8-6.1%.


Subject(s)
Brachytherapy , Cobalt Radioisotopes/therapeutic use , Esophageal Neoplasms/radiotherapy , Radioisotope Teletherapy , Carcinoma, Squamous Cell/radiotherapy , Female , Humans , Male , Middle Aged , Prognosis
9.
Vopr Onkol ; 34(8): 960-6, 1988.
Article in Russian | MEDLINE | ID: mdl-3420839

ABSTRACT

A microbiological model of two-stage experimental carcinogenesis is described. Induction of tumor-like growth in mycelial fungus Fusarium bulbigenum var. blasticola culture was shown to include: (1) initiation by carcinogenic mutagens and (2) promotion or reversible morpho-energy transformation of the cell.


Subject(s)
Fusarium/growth & development , Neoplasms, Experimental/etiology , Animals , Carcinogens/pharmacology , Cell Division/drug effects , Cell Transformation, Neoplastic/chemically induced , Energy Metabolism/drug effects , Fusarium/cytology , Fusarium/drug effects , Mutation , Mycology/methods , Phenotype , Precancerous Conditions/etiology , Time Factors
10.
Article in English | MEDLINE | ID: mdl-3495505

ABSTRACT

Results are reported of a clinical trial on the effect of metronidazole as an adjuvant radiosensitizer in the radiation treatment of cervix carcinomas in advanced stages. Analysis of the results was made with regard to the local clearance of the tumour and with haemoglobin level as a stratifying factor (less than 120 g/l or greater than/equal to 120 g/l at presentation). With no metronidazole treatment, the results in anaemic patients were inferior in comparison to patients with normal haemoglobin level. Metronidazole significantly improved the results in the anaemic cases, but had no effect on the non-anaemic patients. Without stratification with respect to anaemia, no significant difference between the metronidazole-treated and untreated control group was noted. It is concluded that anaemia has a prognostic value, and anaemic patients may represent a particular group for which hypoxic cell sensitizers can be expected to improve the effect of radiotherapy.


Subject(s)
Anemia/complications , Carcinoma/radiotherapy , Metronidazole/administration & dosage , Radiation-Sensitizing Agents/therapeutic use , Uterine Cervical Neoplasms/radiotherapy , Carcinoma/complications , Female , Humans , Prognosis , Uterine Cervical Neoplasms/complications
11.
Med Radiol (Mosk) ; 31(12): 16-9, 1986 Dec.
Article in Russian | MEDLINE | ID: mdl-3540512

ABSTRACT

A clinical trial was performed in 339 patients with Stages IIB, IIIB cervical carcinoma to test the effect of radiotherapy in combination with metronidazole. When the overall material was evaluated, no significant difference in the local clearance rate of tumors in metronidazole-treated and untreated patients was revealed. However, when the case material was subdivided into a group of anemic patients (hemoglobin less than 120 g/l) and a group of patients with normal hemoglobin levels (hemoglobin greater than 120 g/l) the data indicated that metronidazole therapy improved significantly the results in the anemic patients. The results in the non-anemic patients were not influenced, to any significant extent, by the drug.


Subject(s)
Hemoglobins/analysis , Metronidazole/therapeutic use , Uterine Cervical Neoplasms/radiotherapy , Anemia/complications , Clinical Trials as Topic , Female , Humans , Metronidazole/administration & dosage , Middle Aged , Prognosis , Radiotherapy Dosage , Uterine Cervical Neoplasms/blood , Uterine Cervical Neoplasms/complications
12.
Med Radiol (Mosk) ; 31(12): 19-22, 1986 Dec.
Article in Russian | MEDLINE | ID: mdl-3796250

ABSTRACT

Vascularization of laryngeal tumors in 79 patients was determined using a specially devised method. According to the quantity of capillaries in a visual field 3 degrees of vascularization were singled out. A close correlation between the vascularization of tumors and their radiocurability was revealed. In poorly vascularized tumors the local regression and 5-year survival were significantly lower than those in richly vascularized tumors.


Subject(s)
Carcinoma, Squamous Cell/blood supply , Laryngeal Neoplasms/blood supply , Radiation Tolerance , Capillaries , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/radiotherapy , Humans , Laryngeal Neoplasms/mortality , Laryngeal Neoplasms/radiotherapy , Prognosis
14.
Med Radiol (Mosk) ; 30(9): 15-9, 1985 Sep.
Article in Russian | MEDLINE | ID: mdl-4046774

ABSTRACT

The paper is concerned with the results of radiotherapy of inoperable lung cancer patients. The efficacy of dynamic and conventional fractionation regimens was evaluated in relation to the tumor growth rate and size. The tumor growth rate was shown to be of importance for a local radiation effect: the higher growth rate was, the more pronounced tumor lesion and resorption were. A close relationship between the regression intensity and patients' survival was shown.


Subject(s)
Adenocarcinoma/radiotherapy , Carcinoma, Squamous Cell/radiotherapy , Lung Neoplasms/radiotherapy , Adenocarcinoma/mortality , Aged , Carcinoma, Squamous Cell/mortality , Evaluation Studies as Topic , Female , Humans , Lung Neoplasms/mortality , Male , Middle Aged , Radiotherapy Dosage , Time Factors
16.
Cancer ; 49(8): 1597-604, 1982 Apr 15.
Article in English | MEDLINE | ID: mdl-7066865

ABSTRACT

The volume doubling time of primary bone sarcomas and lung metastases was determined by measurements made on serial radiographs. For the primary tumors, the volume doubling times were log-normally distributed and varied in the range of 20--200 days with a mean around 50 days. The volume doubling times of the metastases also showed a log-normal distribution in the range of 10--100 days, but with a mean twice as short as that of the primates. Radiation therapy was given with three--four doses of 20--25 Gy to the tumors that, together with the surrounding normal tissues, had been made hypoxic by the application of a tourniquet. Amputations were not performed unless required eventually by some serious late radiation damage, such as grave functional deficiency, and/or painful fibrosis and ankyloses. In no case did microscopic examination of the amputated tissues reveal the persistence of any viable, neoplastic cells. The five-year survival of a total of 69 patients was 26%. Survival expectancy was found to be closely related to the volume doubling time of the tumors, as was the incidence of the metastases. The data stress the importance of volume doubling time as a predictive factor and indicate, furthermore, that treatment with a few massive radiation doses in combination with tourniquet-induced hypoxia is effective in the local control of bone sarcomas. The several late reaction of the normal tissues to the treatment will, however, require amputations in most of the five-year survivors.


Subject(s)
Bone Neoplasms/radiotherapy , Sarcoma/radiotherapy , Adolescent , Adult , Amputation, Surgical , Bone Neoplasms/mortality , Bone Neoplasms/pathology , Child , Evaluation Studies as Topic , Extremities , Female , Humans , Hypoxia , Lung Neoplasms/pathology , Lung Neoplasms/secondary , Male , Neoplasm Recurrence, Local , Radiotherapy/adverse effects , Sarcoma/mortality , Sarcoma/pathology , Time Factors , Tourniquets , Vascular Diseases/etiology , Vascular Diseases/surgery
18.
Vopr Onkol ; 28(7): 41-5, 1982.
Article in Russian | MEDLINE | ID: mdl-7101827

ABSTRACT

The clinico-roentgenological peculiarities of the course of Ewing's sarcoma depending on tumor localisation were studied in 66 patients (29 in diaphysis and 37 in metaphysis). Tumor growth rates versus localisation (43 cases) and end results (55 cases) wee compared. The malignancy and growth rate of diaphysic tumors appeared to be higher. This was matched by lower survival rates. Statistical data on growth rates of tumor and survival are presented.


Subject(s)
Bone Neoplasms/diagnostic imaging , Sarcoma, Ewing/diagnostic imaging , Adolescent , Adult , Bone Neoplasms/mortality , Bone Neoplasms/physiopathology , Female , Humans , Kinetics , Male , Radiography , Sarcoma, Ewing/mortality , Sarcoma, Ewing/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...